Table 4 Prevalence of LMM, LMS and LPF under different diagnostic criteria
LMM | LMS | LPF | Sarcopenia | |
|---|---|---|---|---|
AWGS 2019 | 172 (17.0%) | 145 (14.4%) | 160 (15.9%) | 87 (8.6%) |
EWGSOP 2 | 172 (17.0%) | 121 (12%) | 75 (7.4%) | 54 (5.4%) |
AWGS 2014 | 172 (17.0%) | 100 (9.9%) | 75 (7.4%) | 60 (5.9%) |
EWGSOP 1 | 293 (29.0%) | 198 (19.6%) | 75 (7.4%) | 123 (12.2%) |
IWGS | 293 (29.0%) | – | 160 (15.9%) | 87 (8.6%) |
FNIH | 198 (19.6%) | 100 (9.9%) | 75 (7.4%) | 23 (2.3%) |
χ2 | 105.72 | 58.02 | 103.86 | 88.15 |
P value | < 0.001* | < 0.001* | < 0.001* | < 0.001* |